Glimpsing Into the Future: Advances in Prenatal Screening for Aneuploidy
A free online accredited CPD program for Canadian physicians and healthcare professionals
Increase knowledge and confidence in discussing options for prenatal screening for trisomy 21, 18, and 13
The Society of Obstetricians and Gynaecologists of Canada (SOGC) and the Canadian College of Medical Geneticists (CCMG) recommend that all pregnant women should be offered prenatal screening for common aneuploidies, in addition to first and second trimester ultrasounds for dating and assessment of fetal anatomy.
A woman should have access to adequate pre-test counselling to make an informed choice, with the understanding that she has the right to accept or decline. Post-test counselling should also be provided to discuss the findings of these investigations and the available additional tests.
Through case studies, the program will educate about these conditions, explore the available screening modalities, and support patient counselling about selecting screening and interpreting screening results.
Program Planning Committee
R. Doug Wilson, MD, MSc, FRCSC
Francois Audibert, MD, MSC
Anne Biringer, MD, CCFP, FCFP
June Carroll, MD, CCFP, FCFP
William Ehman, MD
Shawna Morrison, MS, CGC
1 Mainpro+ Credit
Program available online until: August 15, 2017
This program has been reviewed and co-developed by the Society of Obstetricians and Gynaecologists of Canada
Course Learning Objectives
- Offer options for prenatal screening for trisomy 21, 18, and 13 to all women.
- Differentiate among available prenatal genetic screening modalities for trisomy 21, 18, and 13.
- Counsel patients about the benefits, limitations, test-result interpretation, and outcomes of prenatal screening for trisomy 21, 18, and 13 in the primary care setting.
Questions answered by our expert: R. Doug Wilson, MD, MSc, FRCSC
- Why should practitioners offer prenatal screening to women even when they have average risk pregnancies?
- What are patients’ main concerns about prenatal screening? How can practitioners address these concerns when counselling patients?
- What are the risks associated with prenatal genetic screening?
- In addition to screening for aneuploidy, should a recommendation also be made for screening for microdeletion syndromes?